论文部分内容阅读
目的:观察参脉注射液联合利血生治疗化疗后白细胞减少症的临床疗效。方法:将符合病例入选标准的60例患者随机分为观察组、对照组各30例。两组均给予利血生片、维生素C、维生素B口服,观察组同时给予参麦注射液(每次20mL,1次/d,静脉滴注)治疗。两组疗程均为4周,治疗结束后观察临床疗效及白细胞变化情况。结果:显效率观察组36.67%,对照组20.00%,两组差异显著(P<0.05);总有效率观察组76.67%,对照组66.67%,两组差异显著(P<0.05)。两组白细胞计数情况治疗后1周均迅速降低,与治疗前比差异显著(P<0.05);治疗后2周两组白细胞计数继续下降,与治疗前比差异显著(P<0.05);治疗后3周均有所回升,但观察组[(3.58±0.4)×109/L]较对照组[(2.82±0.6)×109L]改善更为显著(P<0.05);治疗后4周观察组为(4.58±0.85)×109/L,已接近正常,与对照组[(3.20±0.74)×109/L]相比差异显著(P<0.05)。结论:利血生片联合参麦注射液治疗化疗后白细胞减少症临床疗效显著。
Objective: To observe the clinical effect of Shenmai Injection combined with Reserpine on leukopenia after chemotherapy. Methods: Sixty patients who met the selected criteria were randomly divided into observation group (n = 30) and control group (n = 30). Both groups were given reserpine, vitamin C, vitamin B orally, the observation group also given Shenmai injection (each 20mL, 1 / d, intravenous infusion) treatment. Two courses of treatment were 4 weeks after treatment, observe the clinical efficacy and leukocyte changes. Results: The markedly effective rate was 36.67% in the observation group and 20.00% in the control group, with significant difference between the two groups (P <0.05). The total effective rate was 76.67% in the observation group and 66.67% in the control group, with significant difference between the two groups (P <0.05). The white blood cell count of the two groups decreased rapidly 1 week after treatment, which was significantly different from that before treatment (P <0.05). After 2 weeks of treatment, the white blood cell count of the two groups continued to decrease, with significant difference compared with that before treatment (P <0.05) (3.58 ± 0.4) × 109 / L] (P <0.05). Compared with the control group [(2.82 ± 0.6) × 109L], the observation group was significantly improved after 4 weeks (4.58 ± 0.85) × 109 / L, which was close to normal, which was significantly different from that in the control group [(3.20 ± 0.74) × 109 / L] (P <0.05). Conclusion: Reserpine and Shenmai injection are effective in treating leukopenia after chemotherapy.